We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.2B
AUM Growth
+$972M
Cap. Flow
-$111M
Cap. Flow %
-1.21%
Top 10 Hldgs %
15.57%
Holding
2,653
New
86
Increased
398
Reduced
774
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Financials 14.36%
3 Healthcare 13.08%
4 Industrials 10.1%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCBK icon
1501
TriCo Bancshares
TCBK
$1.86B
$461K 0.01%
11,734
TRHC
1502
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$461K 0.01%
8,170
IOVA icon
1503
Iovance Biotherapeutics
IOVA
$2.95B
$459K 0.01%
48,312
ADEA icon
1504
Adeia
ADEA
$3.16B
$459K 0.01%
74,198
IBP icon
1505
Installed Building Products
IBP
$6.54B
$459K 0.01%
9,469
RPT
1506
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$456K 0.01%
37,976
RCM
1507
DELISTED
R1 RCM Inc. Common Stock
RCM
$455K ﹤0.01%
47,026
AIMT
1508
DELISTED
Aimmune Therapeutics
AIMT
$455K ﹤0.01%
20,346
SSP icon
1509
E.W. Scripps
SSP
$310M
$454K ﹤0.01%
21,625
CNR
1510
Core Natural Resources Inc
CNR
$4.64B
$452K ﹤0.01%
13,213
VGR
1511
DELISTED
Vector Group Ltd.
VGR
$451K ﹤0.01%
61,938
KRA
1512
DELISTED
Kraton Corporation
KRA
$451K ﹤0.01%
14,021
AIR icon
1513
AAR Corp
AIR
$5.77B
$451K ﹤0.01%
13,862
SGMO
1514
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$450K ﹤0.01%
47,157
XENT
1515
DELISTED
Intersect ENT, Inc
XENT
$449K ﹤0.01%
13,971
FRPT icon
1516
Freshpet
FRPT
$3.5B
$449K ﹤0.01%
10,616
VNDA icon
1517
Vanda Pharmaceuticals
VNDA
$304M
$448K ﹤0.01%
24,336
MLCO icon
1518
Melco Resorts & Entertainment
MLCO
$2.14B
$447K ﹤0.01%
19,800
LNTH icon
1519
Lantheus
LNTH
$6.59B
$447K ﹤0.01%
18,267
ARR
1520
Armour Residential REIT
ARR
$2.37B
$447K ﹤0.01%
4,577
+697
+18% +$71.4K
TBPH icon
1521
Theravance Biopharma
TBPH
$878M
$446K ﹤0.01%
19,690
FBNC icon
1522
First Bancorp
FBNC
$2.74B
$446K ﹤0.01%
12,826
LNN icon
1523
Lindsay Corp
LNN
$1.17B
$445K ﹤0.01%
4,595
BATRK icon
1524
Atlanta Braves Holdings Series B
BATRK
$3.41B
$445K ﹤0.01%
16,010
UPBD icon
1525
Upbound Group
UPBD
$1.15B
$444K ﹤0.01%
21,277

Similar funds

MetLife Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, MetLife Investment Management held 2,653 positions worth $9.2B, up 12% from $8.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q1 2019 filing shows 86 new, 398 increased, 774 reduced and 85 closed positions. Its largest new stake was Linde: 156,645 shares worth $27.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $48.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2019 buy was Linde: 156,645 shares worth $27.6M.
  • MetLife Investment Management added most to Western Midstream Partners in Q1 2019, an estimated $10.9M increase.
  • MetLife Investment Management's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $48.3M.
  • MetLife Investment Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $14.5M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.2B portfolio in Q1 2019.
  • MetLife Investment Management opened 86 new positions and closed 85 in Q1 2019.
  • MetLife Investment Management's portfolio value rose 12% quarter-over-quarter to $9.2B.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.